Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
2014 · Leukemia · 225 citations
https://doi.org/10.1038/leu.2014.247
K
Kate Burbury
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
4.3K
Citations
31
h-index
77
i10-index
Kate Burbury is an academic researcher from The University of Melbourne. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 31, co-authored 133 publications.
ORCID: 0000-0001-6710-681XPapers by this author
worksFlow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European <scp>LeukemiaNet</scp>
2021 · Cytometry Part B Clinical Cytometry · 41 citations
https://doi.org/10.1002/cyto.b.22046
Telehealth in cancer care during the COVID-19 pandemic
2022 · Journal of Telemedicine and Telecare · 11 citations
https://doi.org/10.1177/1357633x221136305
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry
2023 · Journal of Thrombosis and Thrombolysis · 10 citations
https://doi.org/10.1007/s11239-023-02895-7
“Take the tablet or don’t take the tablet?”—A qualitative study of patients’ experiences of self-administering anti-cancer medications related to adherence and managing side effects
2023 · Supportive Care in Cancer · 9 citations
https://doi.org/10.1007/s00520-023-08122-6
Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial
2024 · JMIR Formative Research · 5 citations
https://doi.org/10.2196/65302
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat